Literature DB >> 27966013

Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.

H Ates1, I Ates2, H Kundi3, F M Yilmaz4.   

Abstract

BACKGROUND: We aimed to examine the value of NT-proBNP, pulmonary artery systolic pressure (PASP), blood pressure index (BPI), and mean arterial pressure (MAP) in the determination of right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (APE). PATIENTS AND METHODS: A total of 547 patients diagnosed with APE were included in the study. Demographic characteristics and comorbid conditions of patients were recorded in patient files. For blood pressure measurement, a calibrated digital blood pressure monitor was used at regular intervals. Blood samples were taken from patients at the time of admission for hemogram, biochemical, and hemostasis blood tests. Echocardiography was performed on all patients to detect RVD and evaluate pulmonary artery pressure.
RESULTS: PASP (p < 0.001), MAP (p < 0.001), diastolic blood pressure (p < 0.001), D‑dimer (p = 0.001), NT-proBNP (p = 0.001), white blood cell (p < 0.001), and platelet (p = 0.001) counts were higher in APE patients with RVD compared with those without RVD, whereas the mean BPI level (p < 0.001) was lower. BPI had a negative correlation with PASP, NT-proBNP, platelet count, and triglyceride levels in patients with RVD. In regression analysis, BPI and PASP were found to be independent predictors of RVD. In receiver operating characteristic curve analysis, BPI (AUC ± SE = 0.975 ± 0.006; p < 0.001) was found to be the best predictor of RVD with a higher sensitivity (92.8%) and specificity (100%).
CONCLUSION: We found that BPI had a better diagnostic discrimination for RVD compared with PASP and NT-proBNP.

Entities:  

Keywords:  Blood pressure; N-terminal pro-BNP; Pulmonary embolisms; Systolic pressure; Ventricular dysfunction

Mesh:

Substances:

Year:  2016        PMID: 27966013     DOI: 10.1007/s00059-016-4513-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  27 in total

1.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

2.  Massive pulmonary embolism.

Authors:  Nils Kucher; Elisa Rossi; Marisa De Rosa; Samuel Z Goldhaber
Journal:  Circulation       Date:  2006-01-23       Impact factor: 29.690

3.  Right ventricular assessment by tissue-Doppler echocardiography in acute pulmonary embolism.

Authors:  Ana Clara Tude Rodrigues; Adriana Cordovil; Claudia Monaco; Laise Guimarães; Alexandre Cury; Gustavo A F Naccarato; Edgar Lira-Filho; Claudio Henrique Fischer; Marcelo Luiz Campos Vieira; Samira Morhy
Journal:  Arq Bras Cardiol       Date:  2013-05-10       Impact factor: 2.000

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction.

Authors:  T Meyer; L Binder; N Hruska; H Luthe; A B Buchwald
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

6.  What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?

Authors:  Hale Ateş; İhsan Ateş; Bülent Bozkurt; Hüseyin Tuğrul Çelik; Duygu Özol; Zeki Yldrm
Journal:  Blood Coagul Fibrinolysis       Date:  2016-04       Impact factor: 1.276

7.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

8.  Association between high platelet indices and proteinuria in patients with hypertension.

Authors:  Ihsan Ates; Mesudiye Bulut; Nihal Ozkayar; Fatih Dede
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

9.  Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management.

Authors:  Jennifer Cowger Matthews; Vallerie McLaughlin
Journal:  Curr Cardiol Rev       Date:  2008-02

10.  Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism.

Authors:  Neşe Dursunoğlu; Dursun Dursunoğlu; Ali İhsan Yıldız; Simin Rota
Journal:  Anatol J Cardiol       Date:  2014-12-31       Impact factor: 1.596

View more
  1 in total

1.  Predictive Value of MPV and Plasma NT-ProBNP Combined with the Simplified Geneva Scale for the Prognosis of Acute Pulmonary Embolism.

Authors:  Jing Wang; Lu Wang; Ling Jin; Xiaolei Rong; Xueshuang Tang; Haina Guo; Xiaochuan Liu; Lei Shi; Guilu Tao
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.